Herantis Pharma
Founded 2008 · 25 employees on LinkedIn · 2 known investors
Find your way into Herantis Pharma
117 people in our graph share verified history with the Herantis Pharma team — schools, employers, funds. One of them is your warm intro.
Ilkka Paananenunlockedknows Antti Vuolanto · together at Teknillinen korkeakoulu-Tekniska högskolan (overlapped)
×6knows the team · via Teknillinen korkeakoulu-Tekniska högskolan
knows the team · via Herantis Pharma
×4knows the team · via Helsinki University of Technology
Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.
Founders & leadership
AV
Antti VuolantoinCEOAntti Vuolanto holds a D.Sc. in Chemistry and has spent over 15 years in biotech leadership roles, including five years as COO and three years as CEO of Herantis Pharma, a Nasdaq-listed pharmaceutical company, alongside prior executive positions at other biotech firms.
Investors · 2
In the news
Frequently asked questions
- What does Herantis Pharma do?
- Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.
- Who are Herantis Pharma's investors?
- Herantis Pharma's investors include Broadview Ventures, Innovestor Ventures.